BIRMINGHAM, Ala., Feb. 13 /PRNewswire-FirstCall/ -- Emageon Inc. (Nasdaq:
EMAG), a leader in enterprise medical information technology systems for
hospitals and health care networks, announced today that it has received the
$9 million that had been placed in escrow with The Bank of New York Mellon by
Health Systems Solutions, Inc. (OTC Bulletin Board: HSSO) in connection with
the parties' merger transaction. The escrowed funds became payable to Emageon
when the merger was not consummated before the close of business on February
11, 2009.
Emageon also announced that it has terminated its amended merger agreement
with Health Systems due to Health Systems' failure to receive all necessary
financing on or before the designated closing date of February 11, 2009.
Emageon continues to evaluate its options in response to these developments.
About Emageon
Emageon provides information technology systems for hospitals, healthcare
networks and imaging facilities. Its enterprise family of solutions includes
RadSuite(TM), HeartSuite(TM) and other specialty suites. All Emageon
solutions are built on a unified Enterprise Content Management system offering
advanced visualization and infrastructure tools for the clinical analysis and
management of digital medical images, reports and associated clinical content.
Emageon's standards-based solutions are designed to help customers enhance
patient care, automate workflow, lower costs, improve productivity and provide
better service to physicians. For more information, please visit
www.emageon.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release regard matters that are
not historical facts and are forward-looking statements within the meaning of
the 'safe harbor' provisions of the Private Securities Litigation Reform Act
of 1995, as amended, including statements regarding expectations as to the
completion of the merger and other transactions contemplated by the merger
agreement, Emageon's intentions or plans to enforce its rights under the
merger agreement and the outcome of the litigation referred to in this
release. These statements are often identified by the use of forward-looking
words such as 'believe,' 'expect,' 'potential,' 'continue,' 'may,' 'will,'
'should,' 'could,' 'would,' 'intend,' 'plan,' 'estimate,' 'anticipate' and
comparable words or the negative version of these and other words. Because
such forward-looking statements contain risks and uncertainties, actual
results may differ materially from those expressed in or implied by such
forward-looking statements.